MET EOYS6 Flashcards

1
Q

State the roles of:
NPY / AgRP neurones [1]
POMC / CART neurones [1]

A

NPY / AgRP neurones: signals hunger and stimulates food intake

POMC / CART neurones: signals satiety and reduces food intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following is a type of diabetes where antibodies produced

Latent Autoimmune Diabetes of Adults
Type two diabetes
Gestatational diabetes
Maturity Onset Diabetes of the Young

A

Which of the following are antibodies produced

Latent Autoimmune Diabetes of Adults type 1.5
Type two diabetes
Gestatational diabetes
Maturity Onset Diabetes of the Young

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the following type of diabetes is usually caused by one gene

Latent Autoimmune Diabetes of Adults
Type two diabetes
Gestatational diabetes
Maturity Onset Diabetes of the Young

A

Which of the following type of diabetes is usually caused by one gene

Latent Autoimmune Diabetes of Adults
Type two diabetes
Gestatational diabetes
Maturity Onset Diabetes of the Young

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PYY has the biggest effect on which part of the GI system

Stomach
Duodenum
Jejunum
Ileum
Colon

A

PYY has the biggest effect on which part of the GI system

Stomach
Duodenum
Jejunum
Ileum
Colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PYY has the is produced from which type of cells:

D cells
A cells
L cells
B cells

A

PYY has the is produced from which type of cells:

D cells
A cells
L cells
B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thiolactone is produced due to a deficiency in which two molecules [2]

What does increased thiolactone levels lead to? [1]

A

B12 & Folate Deficiency

Leads to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A patient with which of the following HbA1c reading would have diabetes

41 mmol/mol
43 mmol/mol
45 mmol/mol
47 mmol/mol
49 mmol/mol

A

A patient with which of the following HbA1c reading would have diabetes

41 mmol/mol
43 mmol/mol
45 mmol/mol
47 mmol/mol
49 mmol/mol - 48 is the cut off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does obesity cause extrinsic insulin resistance? [3]

How does obesity cause intrinsic insulin resistance? [3]

What is net effect of obesity and insulin? [1]

A

Which aspects of obesity causes extrinsic insulin resistance? [3]
* Accumulation of lipids and FFA
* Chronic inflammation
* Altererd adipokiine (cytolines from FA)

How does obesity cause intrinsic insulin resistance? [3]
* Mitochondrial dysfunction
* Ox stress
* ER stress

Overall: causes hyperinsulinaemia, whcih increases lipid synthesis and insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Whats difference between insulin resistance and DMT2?

A

Insulin resistance: adapt by : become bigger, increase in number and produce more insulin (compensatory hyperinsulinaemia)

DMT2: resistance AND failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does islet compensation occur if there is impaired function from obesity of B-cells?

A

As the impacts of obesity occur the susceptible cells will decrease in number/function –> B-cell apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Impaired genetic compensation: genetic component

How do most of the genes associated with DMT2 influence insulin [2]

A

impairing insulin secretion rather than insulin action

Gene risk variants are to do with the regulators of β cell turnover or regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Impaired genetic comepensation: environmental component

Which envrionmental factors within body influence DMT2 infuence? [4]

A

Increased circulating FFAs (lipotoxicity)

Hyperglycaemia (glucotoxicity)

Combination of the two (glucolipotoxicity)

Hyperinsulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Monogenic diabetes? [1]

Specifically how is it caused / insulin affected? [2]

A

Caused by a mutation in a single gene (one of over 40 genes): Means theres 40 types of MODY

Most cases are Maturity Onset Diabetes of the Young (MODY)

Caused by:
* prevent the insulin sensing glucose metabolism in B-cells

  • Due to: impairment of insulin secretion/pancreatic βcell dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is LADA?

What are characteristics of LADA? [2]

A

Latent Autoimmune Diabetes of Adults (LADA): Features of both Type 1 and Type 2 (type 1.5)

Immunologically similar to T1 - produce DMT1 antibodies but destruction is slower than in T1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What HbA1c is used as cut off for diabetes? [1]

A

An HbA1c of 48 mmol/mol (6.5%) is recommended as the cut point for diagnosing diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MoA of Metformin [3]

A

Inhibits gluconeogenesis in the liver
Inhibits CAMP + PKA pathway.
Also increases glucose transport - increasing uptake at skeletal muscle. Opposes insulin resistance through various mechanisms.

From Drugs List:

acts by activation of the AMP-activated protein kinase (AMPK)
increases insulin sensitivity
decreases hepatic gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which treatments for DMT2

inhibitGNG [1]
increase insulin sensistivity [2]
stimulate insulin secretion [2]

two others? [2] ?

A

Inhibits GNG:
* Metformin: inhibits GNG at liver

Increases insulin sensitivity:
* Metformin
* Thiazolidinediones: Enhance GLUT4 uptake into the cell membranes (in adipocytes - so causes weight gain) via PPAR-y gene

Stimulation of insulin secretion:
* Sulfonylureas: close ATP sensitive K chance which regulates insulin secretion
* Prandial glucose regulators: same as above but faster

Others:
* GL1-P receptor agonists
* DPP-4 inhibitors: DPP-4 inhibits GL1-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does DKA occur?

A

In the absence of insulin there is an unrestrained increase in hepatic gluconeogenesis and peripheral glucose uptake by tissues such as muscle is reduced

High circulating glucose levels result in an osmotic diuresis (since increased glucose in urine which pull more water into urine) by the kidneys and consequent dehydration and loss of electrolytes

Peripheral lipolysis occurs leading to an increase in circulating free fatty acids (FFAs) which are then broken down to acetyl-coenzyme A (CoA), but little oxaloacetate within the liver cells and this, in turn, is converted to ketone bodies within the mitochondria. (no Kreb’s cycle)

Ketone bodies are in excess

Ketone bodies dissociate: H+

Causes metabolic acidosis w/ raised anion gap.

Vomiting leads to further electrolye loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is difference between non-proliferative and proliferative retinopathy?

A

Both occur because of damage to BV in back of eye

Non-profilerative: ‘Cotton wool’ dilation of retina veins causes internal haem. oedema causes vision loss

Proliferative: New BV proliferate near optic disc and bleed: detachment of retina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MoA of diabetic nephropathy?

A

PKA activation -> collagen/fibronectin proliferation -> capillary occlusion -> thickening of glomerular basement membrane. PKA activation -> increase in NADPH -> ROS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MoA of diabetic retinopathy?

A

Hyperglycaemia -> increased PKA activity -> reduced retinal blood flow due to vasoconstriction
PKA activity -> vascular permeability angiogenesis -> macular oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

Inhibits liver gluconeogenesis and enhances insulin sensitivity

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

Inhibits liver gluconeogenesis and enahnaces insulin sensitivity

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone

Bind and close K+ channel in beta cells to
depolarise the cell and release insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

Activate PPARγ to reduce insulin insensitivity and better glucose use via gene expression changes

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following drug treatments for diabetes utilise the followng mechanism of actions?

Activate PPARγ to reduce insulin insensitivity and better glucose use via gene expression changes

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
    * Thiazolidinediones e.g Pioglitazone or Rosiglitazone
25
Q

Which of the following drug treatments for diabetes causes weight loss?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following drug treatments for diabetes causes weight loss?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors: excreting glucose
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
26
Q

Which of the following drug treatments for diabetes causes weight gain? [2]

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following drug treatments for diabetes causes weight gain? [2]

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
27
Q

Which of the following has similar action to prandial glucose regulators?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
A

Which of the following has similar action to prandial glucose regulators?

  • Sulfonylureas - e.g. gliclazide, glibenclamide and tolbutamide
  • Metformin
  • SGLT2 Inhibitors
  • Thiazolidinediones e.g Pioglitazone or Rosiglitazone
28
Q

What is the most important factor from diet in reducing CVD? [1]

A

Total calorie intake is most important thing in reducing CVD: particularly saturated fats

29
Q

What happens to arachidonic acid during inflammation? [1]
Due to the action of which enzyme? [1]

A

Escapes from membrane: metabolised to potent inflammatory mediators by phospholipase A2 (PLA2) eg. Prostaglandins

(which is in turn further metabolized by cyclooxygenases (COXs) and lipoxygenases (LOXs) and cytochrome P450 (CYP) enzymes)

30
Q

Under normal B12 and Folate levels what is homocysteine converted to? [1]

Deficient B12 and Folate levels what is homocysteine converted to? [1]
What pathology does this lead to? [1]

A

When the body has Folate and vit B12 (necessary co factors for)
* methionine synthase enzyme: converts homocysteine –> methionine.

BUT: without Folate and B12:
* homocysteine -> homocysteine thiolactone (damages endothelium
= ATHEROSCLEROSIS

31
Q

Chronic deficiency in folate causes low [] and high blood [] levels

A

Chronic deficiency in folate causes low methionine and high blood homocysteine levels

32
Q

When chronic folate deficiency: homocysteine is converted to toxic [] which damages endothelium.

A

When chronic folate deficiency: homocysteine is converted to toxic thiolactone which damages endothelium.

33
Q

What is metabolic syndrome a combination of? [4]

A

Syndrome of increased CVD risk because of:

  • Insulin resistance/ Type II diabetes
  • Abdominal obesity
  • Dyslipidaemia (particularly hypertriglyceridaemia)
  • Hypertension

These factors cluster together more frequently than expected by chance !

34
Q

Which cels in the GI tract sense the luminal envrionment? [1]

Describe how their structure is adapted to their role

A

Enteroendocrine Cells:

Apex: Long processes into lumen + microvilli: for sampling the luminal nutrient environment.

Basal side: stores many vesicles, containing appetite regulating hormones. close to nerve endings - hormones bind to nerve receptors to signal orexigenic or anorexigenic pathways

35
Q

Role of the following of on firing of ECC vesicles?

5HT [1]
Leptin [1]
Ghrelin [1]

A

5HT - increases firing
Leptin - decreases firing
Ghrelin - decreases firing

36
Q

How does leptin affect:

NPY / AgRP neurones [1]
POMC / CART neurones [1]

Is it a short or long term acting hormone? [1]

A

How does leptin affect:

NPY / AgRP neurones: inhibits
POMC / CART neurones: activates

Is it a short or long term acting hormone: long term

37
Q

PYY has what effect on satiety? [1]

A

PYY leads to enhanced satiety

38
Q

Which cells release PYY? [1]
Where is PYY predominately found? [1]
What effect does PYY have on NPY [1] and POMC neurones [1]

A

Which cells release PYY? [1]: L cells in GI tract
Where is PYY predominately found: Colon –> rectum
What effect does PYY have on NPY: inhibits
and POMC neurones: activates

39
Q

GLP-1 is released in response to? [1]
Effect of GLP-1 on blood glucose? [1]
What is GLP-1 like in obese patients? [1]

A

GLP-1 is released in response to? [1]
Food intake

Effect of GLP-1 on blood glucose? [1]
Decreases blood glucose levels

What is GLP-1 like in obese patients? [1]
Reduced in obese patients

40
Q

Effect of pancreatic polypeptide (PP) on appetite? [1]

Effect of oxontymodulin on appetite? [1]

A

pancreatic polypeptide (PP): anorexigenic (decreases appetite)

Oxontymodulin: anorexigenic: decreases ghrelin levels in plasma

41
Q

Ghrelin is [suppressed / increased] in proportion to the calories ingested

A

Ghrelin is suppressed in proportion to the calories ingested

42
Q

AGRP/NPY neurones in arcuate nucleus of hypothalamus are activated by which hormone? [1]

What biochem effect does this have? [1]

A

AGRP/NPY neurones in arcuate nucleus of hypothalamus are activated by which hormone? [1]
Ghrelin

What biochem effect does this have? [1]
Causes a release of Y1 receptors

43
Q

Label A-E xx

A

A: GLP-1
B: PYY
C: Ghrelin
D: Leptin
E: Insulin

44
Q

Role of malonyl-coA? [1]

[] malonyl-coA supresses food intake
[] malonyl coA increases food intake

A

Malonyl-CoA is the substrate for fatty acid synthase, but it is a key determinant for the entry of fatty acids into the mitochondria, and appears to play a pivotal signaling role in appetite regulation.

Increased malonyl-coA supresses food intake
Decreased malonyl coA increases food intake

45
Q

Explain how overall food intake decreases in response to increased energy levels? [1]

Explain how ^ occurs [3]

A

Increased M-CoA - stimulates FA synthesis –» therefore suppresses appetite

More ATP over AMP -> increased denovo FA synthesis -> increased M-CoA -> stimulation of POMC/CART + suppression NYP/AgRP -> decreased food intake

46
Q

Effect of serotonin on appetite?

Effect on POMC and AgRP neurones?

A

Serotonin (5HT): anorexigenic: augmentation of brain 5HT inhibits food intake, depletion promotes weight gain

They increase signalling (simulate) activity in the POMC neurones (via the 5HT2CR)

They decrease signalling in the AgRP neurones (via the 5HT1BR)

47
Q

What class of drug is metformin? [1]

A

biguanide

48
Q

Label the types of diabetic retinopathy [2]

A

A: Non-proliferative - cotton wool spots
B proliferative

49
Q

What type of diabetic retinopathy is depicted? [1]

A

Nonproliferative
Funduscopic features of nonproliferative diabetic retinopathy include retinal hemorrhages and hard exudates (yellow patches)

50
Q

What type of diabetic retinopathy is depicted? [1]

A

Proliferative
The key funduscopic feature of proliferative diabetic retinopathy is neovascularization, seen here around the optic disk.

51
Q

During a routine physical examination, a 65-year-old woman with diabetes mellitus has her balance checked. She is first asked to stand with her feet together (eyes open) and does this well. When she closes her eyes, she begins to fall and is caught by the examiner. Additional neurological findings include absent ankle jerk reflexes and absent perception of vibration at her toes bilaterally.

A lesion to which of the following is the most likely cause of her balance difficulty?

Peripheral nerves
Vestibular system
Upper motor neurons
Cerebellum
Basal ganglia

A

During a routine physical examination, a 65-year-old woman with diabetes mellitus has her balance checked. She is first asked to stand with her feet together (eyes open) and does this well. When she closes her eyes, she begins to fall and is caught by the examiner. Additional neurological findings include absent ankle jerk reflexes and absent perception of vibration at her toes bilaterally.

A lesion to which of the following is the most likely cause of her balance difficulty?

Peripheral nerves
Vestibular system
Upper motor neurons
Cerebellum
Basal ganglia

52
Q

Which of the following is most associated with this skin condition?

Polycystic ovarian syndrome
Graves’ disease
Small cell lung cancer
Addison’s disease
Methotrexate use

A

Which of the following is most associated with this skin condition?

Polycystic ovarian syndrome
Graves’ disease
Small cell lung cancer
Addison’s disease
Methotrexate use

This is a typical appearance of acanthosis nigricans; symmetrical, dark, ‘velvety’ plaques which arise on the neck, axillae and groin creases in conditions associated with raised insulin, such as:

Obesity
Type 2 diabetes
Polycystic ovarian syndrome
Cushing’s disease

53
Q

Which of the following are released from the stomach:

A: GLP-1
B: PYY
C: Ghrelin
D: Leptin
E: Insulin

A

Which of the following are released from the stomach:

A: GLP-1
B: PYY
C: Ghrelin
D: Leptin
E: Insulin

54
Q

Which of the following is the action of PYY?

Inhibits excitatory appetite neurones

Stimulates excitatory appetite neurones

Inhibits inhibitory appetite neurones

None of the above

A

Which of the following is the action of PYY?

Inhibits excitatory appetite neurones

Stimulates excitatory appetite neurones

Inhibits inhibitory appetite neurones

None of the above

55
Q

Which of these transmitters is stimulatory for appetite?

NPY

POMC

a-MSH

CART

A

Which of these transmitters is stimulatory for appetite?

NPY

POMC

a-MSH

CART

56
Q

Which peptide hormone released by cells in the ileum and colon suppresses appetite?

Insulin

Leptin

Ghrelin

PYY (peptide tyrosine tyrosine)

A

Which peptide hormone released by cells in the ileum and colon suppresses appetite?

Insulin

Leptin

Ghrelin

PYY (peptide tyrosine tyrosine)

57
Q

Release of which of the following substances is inhibitory for appetite?

Ghrelin

AgRP (Agouri-related peptide)

NPY (Neuropeptide Y)

CART (cocaine- and amphetamine regulated transcript)

A

Release of which of the following substances is inhibitory for appetite?

Ghrelin

AgRP (Agouri-related peptide)

NPY (Neuropeptide Y)

CART (cocaine- and amphetamine regulated transcript)

58
Q

Alpha-MSH and Beta-endorphin may be produced from which neurotransmitter?

CART (cocaine- and amphetamine regulated transcript)

POMC (pro-opiomelanocortin)

NPY (Neuropeptide Y)

AgRP (Agouri-related peptide)

A

Alpha-MSH and Beta-endorphin may be produced from which neurotransmitter?

CART (cocaine- and amphetamine regulated transcript)

POMC (pro-opiomelanocortin) POMC can be cleaved into other neurotransmitters such as alpha-MSH and beta-endorphin. These also act to suppress hunger.

NPY (Neuropeptide Y)

AgRP (Agouri-related peptide)